Behcet Syndrome
25
4
4
13
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.0%
3 terminated out of 25 trials
81.3%
-5.3% vs benchmark
8%
2 trials in Phase 3/4
31%
4 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (25)
Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome
Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
Upadacitinib for Refractory Behcet's Syndrome
AutoInflammatory Disease Alliance Registry (AIDA)
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity
Gut Microbiota and Behcet's Syndrome: a Dietary Intervention Trial (MAMBA Study)
Sleep Related Breathing Disorders, Anxiety, Depression and Quality of Life Assessment in Behcet's Disease
Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers
Golimumab for the Treatment of Refractory Behcet's Uveitis
Zinc Supplementation and Behçet's Syndrome
Uses of Tacrolimus in Behcet Disease
Evaluation of the Psychoeducation Program Given to Behcet's Patients in the Context of the Roy Adaptation Model
Tocilizumab for the Treatment of Refractory Behcet's Uveitis
Neuro-ultrasound Assessment in Behcet's Disease
Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography
A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
Erectile Dysfunction in Patients With Non Ocular Behçet's Disease
Frequency of Fibromyalgia in Behcet Disease
Dietary Interventions and Butyrate Production in Behçet's Patients